Navigation Links
Testicular Cancer Patients Have Improved Reproductive Outcomes After Treatment

The survival rate of patients with testicular cancer has increased significantly over the past several years. What more, new research has now shown that fatherhood is a reachable possibility for many men who survive the disease.//

Testicular cancer is the most common form of cancer among men ages 20 to 40 and is slightly more common on the right side than on the left. The cause for the cancer is not known exactly. However, a combination of congenital (present right form birth) and acquired factors is believed to play a significant role.

The most common symptom associated with testicular cancer is painless enlargement of the testis accompanied by a sensation of heaviness. Self-examination plays a very important role in the early detection and treatment of testicular cancer. Surgery, radiotherapy and chemotherapy are the treatment options available.

A ray of hope left for the patients affected with testicular cancer is that it has a high cure rate, if detected early. However, the treatment has been known to affect the fertility potential of the patient. A follow up study combined with research purpose, conducted on a group of testicular cancer patients revealed that about one-third of the follow up patients attempted to father a child after treatment. Seventy-one percent of the men were successful within 15 years of treatment and 76 percent had the same success within 20 years.

Furthermore, the chance of successful conception was found to be dependent on the type of treatment as anticipated. Men treatment with high doses of chemotherapy had a 48 % success while the success rate for those followed by surveillance alone after the cancerous testicle was removed was much higher (92 %). Assisted reproductive techniques have helped these patients to a larger extent (22 %). The study results highlight the finding that the ability to conceive has increased over the years. It would be important however to preserve the sperm sample by c ryopreservation prior to chemotherapy as it is impossible to predict the fertility outcome on an individual basis.
'"/>




Related medicine news :

1. Fertility After Testicular Cancer Questioned
2. Life After Testicular Cancer
3. New Screening Method Found To Detect Testicular Cancer In Its Initial Stages
4. Testicular cancer linked to high cholesterol
5. Carboplatin Drug Is More Effective Than Radiation Therapy For Testicular Cancer
6. Treating Testicular Cancer With A Single Dose Of Chemotherapy
7. Testicular cancer identified
8. New Treatment Option For Testicular Cancer
9. Decline in Paternity Rates Following Treatment for Testicular Cancer
10. Human Testicular Cells Would Help In Stem Cell Research
11. An Eye on Increase in Testicular Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... ... Ellevate Network, the leading network for professional women, brought together some of ... their inaugural Summit in New York City in June. The event was livestreamed with ... 3 million. To watch the Mobilize Women video, click here . , ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “The Journey: From ... every danger possible to save lost souls in the Philippines. “The Journey: From the ... is a dedicated teacher of the Bible. She has taught all ages and currently ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. ... recently contributed a medical article to the newly revamped Cosmetic Town journal ... spotlights the hair transplant procedure known as Follicular Unit Extraction (FUE). ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations (HLI), ... software tool, and the Cancer Patient Education Network (CPEN), an independent professional organization ... a new strategic alliance. , As CPEN’s strategic partner, HLI will help ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically ... announced three leadership team developments today:   ... ... Tom ... Veteran medical device executive Josh Stopek , PhD, who ...
Breaking Medicine Technology: